European Association for the Study of the Liver
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update
Abstract
Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for the evaluation of liver disease severity and prognosis, focusing on the topics for which relevant evidence has been published in the last 5 years.
Source and rights
Published by Journal of hepatology, 2021. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- European Association for the Study of the Liver
- Published
- 2021
- Applies to
- 🇪🇺 Europe
- Scope
- Regional
- Journal
- Journal of hepatology
- PubMed
- 34166721
- Added to Prognia
- 23 July 2026
More in gastroenterology and hepatology
- Practical management of glucagon-like peptide-1 receptor agonists in gastroenterology: a position paper by the Italian Society of Gastroenterology (SIGE)European Respiratory Society · 2026
- AGA Clinical Practice Update on Diagnosis and Treatment of Hemorrhoids: Expert ReviewAmerican Gastroenterological Association Institute · 2026
